UnitedHealth Group Incorporated (NYSE:UNH) does about 3.32M shares in volume on a normal day but saw 3416864 shares change hands in Monday trading. The company now has a market cap of 451.72B USD. Its current market price is $485.81, marking a decrease of -0.19% compared to the previous close of $486.72. The 52 week high reached by this stock is $558.10 whilst the lowest price level in 52 weeks is $445.73. The script in recent trading has seen the stock touch a high of $490.10 and a low of $481.39.
UnitedHealth Group Incorporated (UNH) has a 20-day trading average at $502.75 and the current price is -12.95% off the 52-week high compared with 8.99% distance from its 52-week low. The 50-day simple moving average of the closing price is $519.47 and its 200-day simple moving average is $517.48. If we look at the stock’s price movements over the week, volatility stands at 2.07%, which increases to 2.11% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.25 to suggest the stock is neutral.
26 analysts observing the UnitedHealth Group Incorporated (UNH) stock have set the 12-month price targets for the company’s shares at between $480.00 and $650.00. The consensus objective for the share price is $598.22, suggesting that the stock has a potential upside of 18.79% over the period. The median price target is 19.03% away from the current levels at $600.00.
FactSet Research has provided data showing that 26 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 3 advise that it is a overweight. 19 analysts have rated it as a buy and 3 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 23, 2022 when Morgan Stanley resumed the stock to “Overweight” and issued a price target of $587. Raymond James downgraded the stock to “Outperform” from Strong Buy on November 21, 2022 at a price target of $615. Loop Capital initiated its price target at $575.
The current price level is -3.77%, -6.72%, and -6.15% away from its SMA20, SMA50, and SMA200 respectively, with the UNH price moving above the 50-day SMA on January 23. UnitedHealth Group Incorporated (UNH) stock is down -0.77% over the week and -6.61% over the past month. Its price is -8.37% year-to-date and 4.93% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of $5.79 above consensus estimates by $0.37. The company’s next earnings report is expected on 04/18/2023, with forecasts estimating quarterly EPS at $5.16 and $22.03 for whole year. UNH’s earnings per share are forecast to grow by 15.80% this year and 13.20% over next year. Expected sales for next quarter are $88.29 billion, which analysts say will come at $323.33 billion for the current fiscal year and next year at $352.53 billion. In addition, estimates put the company’s current quarterly revenue at an average of $81.97 billion.
Its 12-month price target is $600.00. To reach the target analysts have set, the stock logically needs to grow 18.79 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $480.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $650.00.
Outstanding shares total 935.00M with insiders holding 0.47% of the shares and institutional holders owning 90.12% of the company’s common stock. The company has a return on investment of 16.50% and return on equity of 25.00%. The price to earnings ratio (P/E ratio) amounts to 22.93 while the forward price to earnings ratio is 17.17. The beta has a value of 0.72. Price to book ratio is 6.08 and price to sales ratio is 1.39.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in UnitedHealth Group Incorporated (UNH) to 28,415,783 shares, mirroring a recent increase by 0.77%. Vanguard Total Stock Market Index added 0.22 million shares of UnitedHealth Group Incorporated common stock bringing its total worth to about $15.07 billion at the end of recent close, SEC documents show. Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by Vanguard 500 Index Fund, which added 0.17 million shares to end up with 21,597,731 shares worth $11.45 billion. American Funds Growth Fund of Ame cut their holdings by -17.50% in the company over the course of the most recent quarter. It now holds a 1.34% position in UnitedHealth Group Incorporated thanks to 12.49 million shares amounting to $6.62 billion.